Related Experiment Video
Updated: Jul 30, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Endocarditis caused by drug-resistant Streptococcus pneumoniae in a child
C Pancharoen1, C Thisyakorn, P Lertsapcharoen
1Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Abstract:
We report a case of infective endocarditis caused by drug-resistant Streptococcus pneumoniae. Cefazolin or cefotaxime therapy induced a partial response. Treatment with vancomycin was successful. This microorganism may be more significant in endocarditis in areas with a high prevalence of drug-resistant Streptococcus pneumoniae.
Insights
Infective endocarditis caused by drug-resistant Streptococcus pneumoniae can be successfully treated with vancomycin. This finding is significant in regions with high prevalence of antibiotic-resistant bacteria.
Area of Science:
- Infectious Diseases
- Cardiology
- Microbiology
Background:
- Infective endocarditis (IE) is a serious infection of the heart valves.
- Drug-resistant Streptococcus pneumoniae presents a growing challenge in clinical settings.
- Understanding treatment outcomes for resistant pathogens is crucial for patient management.
Observation:
- A case of infective endocarditis was identified.
- The causative agent was identified as drug-resistant Streptococcus pneumoniae.
- Initial treatment with cefazolin or cefotaxime resulted in only partial response.
Findings:
- Vancomycin therapy was ultimately successful in treating the infective endocarditis.
- This indicates vancomycin's efficacy against drug-resistant Streptococcus pneumoniae in IE.
- The microorganism's significance in endocarditis may increase in areas with high resistance rates.
Implications:
- Vancomycin should be considered for treating infective endocarditis caused by drug-resistant Streptococcus pneumoniae.
- Clinicians should be aware of the rising prevalence of resistant Streptococcus pneumoniae in endocarditis cases.
- Further research into optimal therapeutic strategies for resistant bacterial endocarditis is warranted.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
08:25Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Mechanism of Antibiotic Resistance in MRSA
Pneumonia I: Introduction